Company · CIK 1840229

# MiNK Therapeutics, Inc.

| CIK | [1840229](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001840229) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | NY |
| Listed | INKT (Nasdaq) |
| First annual or quarterly report | 2021-11-29 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-291388 | Shelf Effective | 2025-11-07 | 2025-12-11 | 2 |
| 333-268143 | Shelf Effective | 2022-11-03 | 2025-08-22 | 4 |
| 333-281522 | Shelf Effective | 2024-08-13 | 2024-08-16 | 2 |
| 333-259503 | IPO Final prospectus | 2021-09-14 | 2021-10-15 | 4 |

## Filings

 13

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-12-11 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1840229/999999999525003665/9999999995-25-003665-index.htm) Declared effective | 333-291388 | 9999999995-25-003665 |
| 2025-11-07 | [S-3](https://www.sec.gov/Archives/edgar/data/1840229/000119312525272532/0001193125-25-272532-index.htm) Shelf registered | 333-291388 | 0001193125-25-272532 |
| 2025-08-22 | [424B5](https://www.sec.gov/Archives/edgar/data/1840229/000119312525186417/0001193125-25-186417-index.htm) Shelf takedown | 333-268143 | 0001193125-25-186417 |
| 2025-07-15 | [424B5](https://www.sec.gov/Archives/edgar/data/1840229/000119312525159014/0001193125-25-159014-index.htm) Shelf takedown | 333-268143 | 0001193125-25-159014 |
| 2024-08-16 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1840229/999999999524002571/9999999995-24-002571-index.htm) Declared effective | 333-281522 | 9999999995-24-002571 |
| 2024-08-13 | [S-3](https://www.sec.gov/Archives/edgar/data/1840229/000119312524199818/0001193125-24-199818-index.htm) Shelf registered | 333-281522 | 0001193125-24-199818 |
| 2022-11-08 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1840229/999999999522003237/9999999995-22-003237-index.htm) Declared effective | 333-268143 | 9999999995-22-003237 |
| 2022-11-03 | [S-3](https://www.sec.gov/Archives/edgar/data/1840229/000119312522277009/0001193125-22-277009-index.htm) Shelf registered | 333-268143 | 0001193125-22-277009 |
| 2021-10-15 | [424B4](https://www.sec.gov/Archives/edgar/data/1840229/000119312521300184/0001193125-21-300184-index.htm) Final prospectus | 333-259503 | 0001193125-21-300184 |
| 2021-10-14 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1840229/999999999521003881/9999999995-21-003881-index.htm) Declared effective | 333-259503 | 9999999995-21-003881 |
| 2021-10-12 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1840229/000119312521296215/0001193125-21-296215-index.htm) Amendment | 333-259503 | 0001193125-21-296215 |
| 2021-09-14 | [S-1](https://www.sec.gov/Archives/edgar/data/1840229/000119312521271914/0001193125-21-271914-index.htm) Registration filed | 333-259503 | 0001193125-21-271914 |
| 2021-01-22 | [DRS](https://www.sec.gov/Archives/edgar/data/1840229/000095012321000524/0000950123-21-000524-index.htm) Draft made public | 377-04074 | 0000950123-21-000524 |

[All filings of this company](https://equitycapital.markets/filings?cik=1840229) · [CSV](https://equitycapital.markets/filings.csv?cik=1840229)

---
Source page: https://equitycapital.markets/company/1840229 · Data: U.S. SEC EDGAR · CC BY 4.0